Fri.May 30, 2025

article thumbnail

HIV Drug Shows Potential as Oral Treatment for Diabetic Macular Edema

Drug Topics

The results show promise, as vision typically improves the most during the first 4 weeks, but with lamivudine, vision continued to improve in the following 4 weeks.

247
247
article thumbnail

Opinion: STAT+: The World Health Assembly’s giant leap on rare diseases

STAT

On May 24, the World Health Assembly, the governing body of the WHO, ratified landmark legislation that, if implemented fully, will change the future for people living with rare diseases. It calls for concrete action plans that will have far-reaching impacts across health care systems in diverse nations around the globe. It’s a historic moment in decades-long efforts to appropriately address the needs of the approximately 400 million people who suffer from rare diseases.

100
100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Grants Fast Track Designation to Drug Candidate for Celiac Disease

Pharmacy Times

The FDA grants fast track designation to TEV-53408, a promising treatment for celiac disease designed to address gluten intolerance and improve patient outcomes.

FDA 94
article thumbnail

STAT+: Up and down the ladder: The latest comings and goings

STAT

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

88
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

NLA 2025: The Complementary Roles of ANGPTL3 and ANGPTL4 in Lipid Regulation and Therapy

Pharmacy Times

Sander Kersten, PhD, discusses the distinct roles of ANGPTL3 and ANGPTL4 in lipid metabolism, their interactions with key enzymes, the therapeutic potential of targeting these pathways in lipid-lowering strategies, and important considerations for pharmacists counseling patients on emerging ANGPTL-targeted therapies.

65
article thumbnail

Sophie Lebakken: Finding a home in MLS

Blog: Ask a Student Pharmacist

Sophie Lebakken: Finding a home in MLS wils1838 Fri, 05/30/2025 - 10:25 Author: Erin Wilson Sophie Lebakken took a journey through three different majors and three different colleges at the University of Minnesota to find the right place for her gifts, which turned out to be the Medical Laboratory Sciences (MLS) program. First, she tried biomedical engineering, but only enjoyed the biomedical aspect.

More Trending

article thumbnail

Joelle Simpson: Working in the spotlight and behind the scenes

Blog: Ask a Student Pharmacist

Joelle Simpson: Working in the spotlight and behind the scenes eomizowh Fri, 05/30/2025 - 11:15 Author: Erin Wilson Miss South Dakota is pursuing her Bachelors degree in Medical Laboratory Sciences (MLS), but she must defer a year to tend to the duties of her crown and to prepare for the 2025 Miss America pageant in January. This is Joelle Simpsons first year competing in pageants, though shes used to being in the spotlight; shes South Dakotas first quadruple gold medalist figure skater and a pr

52
article thumbnail

Innovation, real-world data, and precision medicine: Pierre Fabre and the lung cancer space

pharmaphorum

Explore how Pierre Fabre and experts like Thodore Leondaridis, Dr Francesco Hofmann, and Nuria Perez Cullell are revolutionising the lung cancer space through innovation, real-world data, and precision medicine. Gain insights into their groundbreaking work.

52
article thumbnail

Quality Professionals Gather in Tampa at the 2025 PQA Annual Meeting

PQA

PQA members and health care quality professionals gathered in Tampa, Fla., May 19-21, for the 2025 PQA Annual Meeting. Over those three days, health care executives and quality professionals from pharmacies, health plans, health care providers, pharmacy benefit managers, life sciences companies, technology vendors, research institutions, academia and more addressed top issues and emerging trends in medication quality, measure development and implementation, care transformation and technology.

article thumbnail

Novel Agents, Promising Data: The Evolving Landscape of Oncology Care

Pharmacy Times

Groundbreaking oncology drugs transform treatment for glioblastoma, HR+ breast cancer, and small cell lung cancer.

87
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

How Going to a Conference Can Strengthen Your Microbiological Knowledge

Pharmig

Pharmaceutical microbiology conferences give attendees the opportunity to learn, grow, and meet interesting colleagues. See the benefits of Pharmig events now. The post How Going to a Conference Can Strengthen Your Microbiological Knowledge appeared first on Pharmig.

57
article thumbnail

ASCO 2025: Racial Disparities and Advanced Staging in Early-Onset Colorectal Cancer

Pharmacy Times

A study of early-onset colorectal cancer found significant racial disparities, with younger patients more frequently diagnosed at advanced stages.

70
article thumbnail

Wes Flint: forging a new path in medical laboratory science

Blog: Ask a Student Pharmacist

Wes Flint: forging a new path in medical laboratory science eomizowh Fri, 05/30/2025 - 11:18 Author: Erin Wilson Before finding their way to the College of Pharmacy, student Wesley Flint sought a middle ground between a love for chemistry and biology and an aspiration to work in the medical field. He first heard of medical laboratory sciences during orientation at a different university described as test tubes, petri dishes and turning peoples fluids into numbers for treatment.

article thumbnail

Patient Reported Outcomes Show Improved Symptoms With Zongertinib for HER2-Mutated Non-Small Cell Lung Cancer

Pharmacy Times

Zongertinib shows significant benefits in managing symptoms and improving quality of life for patients with HER2-mutated non-small cell lung cancer.

65
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Maddie Everson: Improving everyday lives

Blog: Ask a Student Pharmacist

Maddie Everson: Improving everyday lives eomizowh Fri, 05/30/2025 - 11:22 Maddie Everson with her client. Author: Erin Wilson Ph Before switching to a pre-occupational therapy track, student Maddie Everson was pursuing physical therapy for her undergraduate degree in exercise science at the University of Wisconsin LaCrosse. I just like the idea of helping people in their everyday lives and making their days easier, rather than rehabilitation from an injury, Everson said.

52
article thumbnail

Centennial Pharmacy Services in Pennsylvania Highlights a Lifelong Passion for Patient Care

Pharmacy Times

The pharmacy is proud to be community focused and patient centered.

article thumbnail

Hailey Molloy: a creative and historical approach to OT

Blog: Ask a Student Pharmacist

Hailey Molloy: a creative and historical approach to OT eomizowh Fri, 05/30/2025 - 11:22 Author: Erin Wilson From a young age, occupational therapy (OT) student Hailey Molloy knew she wanted to help people, though she wasnt yet sure how. Her first exposure to OT was young, when her teenage cousin was involved in a severe car accident, resulting in a traumatic brain injury that was expected to end her life.

article thumbnail

Streamlining Pain Management: Shore Medical Center's Pharmacist-Driven Opioid Conversion Initiative

Pharmacy Times

Shore Medical Center enhances patient safety with a pharmacy-driven intravenous to oral opioid conversion protocol, minimizing risks and improving pain management.

65
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

OT student seeks to support families waitlisted for diagnostic evaluation

Blog: Ask a Student Pharmacist

OT student seeks to support families waitlisted for diagnostic evaluation eomizowh Fri, 05/30/2025 - 11:40 For her doctorate capstone project, occupational therapy student Bruktawit Zewdie is interviewing parents of children on the autism spectrum who have been waitlisted for evaluation or intervention. Shes working with the TeleOutreach Center at the Masonic Institute for the Developing Brain, which she was introduced to during her time as a MNLEND fellow.

52
article thumbnail

Elecsys PRO-C3 Test Aims to Improve Precision Evaluation of Liver Fibrosis Severity

Pharmacy Times

The test offers health care professionals a simple and efficient method of identifying patients with liver fibrosis of varying severity.

65
article thumbnail

Do amitriptyline and alcohol mix?

The Checkup by Singlecare

Amitriptyline is a tricyclic antidepressant commonly prescribed to treat depressive disorders , certain types of chronic pain (like fibromyalgia ), and occasionally sleep issues. It works by increasing levels of specific neurotransmitters in the brain, particularly norepinephrine and serotonin. Its typically taken daily, on a long-term basis. If you’ve just been prescribed amitriptyline, you might be wondering whether it’s ever okay to take part in happy hour while taking this medica

52
article thumbnail

Cellular Senescence is a Central Driver of Chronic Kidney Disease-Related Kidney Fibrosis

Pharmacy Times

Researchers explore cellular senescence's role in kidney fibrosis, highlighting potential therapies to combat chronic kidney disease progression.

65
article thumbnail

FDA rejects Stealth Bio’s Barth syndrome treatment after 16.5-month review

Pharmaceutical Technology

Stealth Bio has cut 30% of its workforce as it eyes a resubmission based on discussions with the FDA.

FDA 52
article thumbnail

Helping Patients Navigate GLP-1 Therapy: Practical Strategies for Pharmacists

Pharmacy Times

Katherine H. Saunders, MD, DABOM, explores the role of pharmacists in supporting long-term weight management with GLP-1 therapies, including strategies for counseling on lifestyle interventions, managing adverse effects, and ensuring patients receive individualized, evidence-based care.

65
article thumbnail

Astellas and Evopoint sign ADC licensing deal

Pharmaceutical Technology

Astellas Pharma has signed an exclusive licensing agreement with Evopoint Biosciences for XNW27011, a CLDN18.2-targeting clinical-stage ADC.

52
article thumbnail

Streamlining the Route of Administration of Monoclonal Antibody Therapies for Better Patient Outcomes in the NSCLC Population

Pharmacy Times

A panelist discusses how the PALOMA-3 study demonstrated that subcutaneous amivantamab is noninferior to intravenous (IV) administration with significantly lower infusion-related reaction (IRR) rates (13% vs 66%), shorter administration time (5 minutes vs 5 hours), higher patient-reported convenience (85% vs 35%), and improved clinical outcomes, making it potentially preferable for most eligible patients once FDA approved.

FDA 65
article thumbnail

Daiichi Sankyo and MSD withdraw US application for lung cancer BLA

Pharmaceutical Technology

Daiichi and MSD have voluntarily withdrawn the BLA in the US for their patritumab deruxtecan for treating non-small cell lung cancer (NSCLC).

52
article thumbnail

Steroid-Refractory cGVHD: A Look at FDA-Approved Options

Pharmacy Times

Panelists discuss how recent FDA approvals and evolving evidence for second-line treatments, including ruxolitinib, ibrutinib, and belumosudil, are reshaping chronic graft-vs-host disease (cGVHD) management by offering tailored, evidence-based options for steroid-refractory patients.

FDA 65
article thumbnail

How Recent Executive Orders Impact the Drug Pricing Landscape

Pharmaceutical Commerce

Alice Valder Curran outlines the steps manufacturers should take to better prepare for upcoming executive actions on drug pricing and market access.

52
article thumbnail

Tailoring Therapy: Weighing Evidence, Organ Involvement, and Route of Administration

Pharmacy Times

Panelists discuss how factors such as patient preferences, disease severity, organ-specific involvement, and adverse effect profiles influence the selection of second-line therapies for steroid-refractory chronic graft-vs-host disease (cGVHD) in the context of multiple FDA-approved agents.

FDA 65
article thumbnail

Pharmacists Play Key Role in Addressing Social Determinants of Health | PQA 2025

Drug Topics

In a session at PQA 2025, presenters discussed the impact of SDoH on health outcomes and how pharmacy teams can identify and address barriers.

450
450
article thumbnail

Personalized Care: How Do NSCLC Treatment Modifications and Patient-Specific Factors Impact Health Outcomes?

Pharmacy Times

A panelist discusses how maintaining efficacy while preserving quality of life requires personalized approaches including dose adjustments or agent rotation based on specific toxicities, and how selecting the appropriate EGFR inhibitor depends on patient comorbidities, performance status, baseline conditions (such as interstitial lung disease or cardiac issues), and patient preferences.

65
article thumbnail

CVS, Express Scripts Sue to Overturn Arkansas Law Banning PBMs From Owning Pharmacies

Drug Topics

In the suit, the companies claim the law puts an unconstitutional restriction on interstate commerce.

442
442